[ad_1]
According to the 28th Korean Association of Hepatology, 240 million people were infected with hepatitis B and 150 million people were infected with the hepatitis C virus. hepatitis B and hepatitis C develop as deadly liver diseases such as cirrhosis and liver cancer when they are not treated properly
According to research, 74.2% of hepatocellular carcinoma in Korea is caused by chronic hepatitis B and 8.6% by hepatitis C.
Specifically, hepatitis A is an increase in the number of patients in the summer when it is hot. Hepatitis A occurred more than 15,000 cases in 2009 and was designated as an infectious disease of first appearance in 2010, the following year. When the hepatitis A virus enters the body, the symptoms appear after an average latency period of about 4 weeks. Initially, fever such as fever, body fatigue or muscle pain occurs, appetite decreases and nausea is often misdiagnosed as a cold body or gastritis. Then the color of the urine becomes like a coke, and the yellowish yellow color appears in the white of the eye.
Hepatitis A, most of which are characterized by acute hepatitis, have no particular treatment in addition to taking adequate nutrition and stability. In addition to personal hygiene, prevention through vaccination is the most effective disease management method.
Hepatitis B is the most common hepatitis in Korea, accounting for 5 to 8% of the total population (2.5 to 3.5 million people). It is estimated that about 400,000 patients become chronic due to chronic inflammation for 6 months or more.
In children infected with hepatitis B, more than 80% develop chronic hepatitis. Currently, immunoglobulin immunization is the most effective prevention method for babies born to patients with chronic hepatitis B. Hepatitis B can be prevented by three vaccinations, regardless of the adult or the child.
Vaccine targets are all infants and adults who do not have both the antibody against hepatitis B and the antigen. In particular, families of carriers of hepatitis B, patients who require frequent blood transfusions and hemodialysis patients are at high risk of being exposed to the hepatitis B virus, they should so be immune.
By cons, the number of patients who visited the hospital with hepatitis C is 409569 in 2016, an increase of 8% compared to 40 890 in 2012. (Statistics of & 9 [[[)healthinsuranceevaluation)Theactualnumberofpatientsshouldbehigher
Many people do not know that they have hepatitis C because they have no symptoms. Hepatitis C is a disease whose cure rate is higher than that of early treatment, but it often progresses to complications because it can not be treated on time, and it It is possible that it spreads involuntarily to other people.
Hepatitis C does not increase much the symptoms and often makes the liver hard, so often without symptoms.
If cirrhosis of the liver or hepatocarcinoma occurs, then liver transplantation is necessary, or even can not reach the state can not use the hand.
Until recently, the treatment of hepatitis C was very difficult and complicated, such as injecting drugs and taking oral medications, but the number of new drugs has recently has been reduced and the effect has improved. Treatment can cure the disease and prevent progression to cirrhosis and liver cancer.
Kim Soon-gwan, director of the Busan Health Promotion Center, said, "Early detection and early treatment are important because hepatitis B and C can progress to cirrhosis and liver cancer if they are not processed. Hepatitis A and B are preventative vaccines, so it is recommended to conduct inoculation after an antibody test.
[디지털뉴스국 이미연 기자]
[ⓒ 매일경제 & mk.co.kr, 무단전재 및 재배포 금지]
Source link